Generation Bio Co.
GBIONext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for GBIO. That does not mean none is planned.
Get an email about GBIO's next catalysts
Track Generation Bio Co. (GBIO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Lymphoma
1 drug in this indication
Ovarian Cancer
1 drug in this indication
Graves' Disease
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
When is Generation Bio Co.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Generation Bio Co. (GBIO) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track GBIO biotech catalysts?β
Add GBIO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Generation Bio Co.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
